Robots for Cell Therapy manufacturing

ROBOTS manufacturing gene modified cell therapies to achieve industrial scale.

cluster UP

Key technology features

A unique, modular approach, to Cell Therapy automation that reduces manufacturing bottlenecks and minimizes human contamination.

Multiply Labs' robotic systems for cell therapy manufacturing are being developed in a Consortium with Cytiva, Thermo Fisher, Charles River Laboratories and UCSF.

To learn more, and to request a spot in our commercial deployment program, contact us.

Compatibility

Compatible with the market-leading GMP instruments

Bioreactor
cytiva
Incubator
thermofisher
Testing
charles-river-1
products-03a

Each robotic module contains a single instrument; multiple modules are used together to automate a process

Flexibility

Any process can be implemented by selecting the corresponding combination of modules

Adaptable

It's easy to remove, add and swap modules

capsules-05

Parallelism (high-throughput)

A fully automated system where “fast” modules feed multiple parallel bioreactor modules

Want to learn more? Reach out!

Jason Arcediano

Recent News

News
Wuxi-AppTec

WuXi STA and Multiply Labs announce partnership and successfully deploy robotic manufacturing system for personalized drugs

2 December 2022
WuXi STA and Multiply Labs announce partnership and successfully deploy robotic manufacturing system for personalized drugs Personalized doses can now be filled into single- or multi-compartment...
Read More
News
Consortium to automate cell therapy manufacturing welcomes Thermo Fisher and Charles River Labs

Consortium to automate cell therapy manufacturing welcomes Thermo Fisher and Charles River Labs

6 May 2022
...
Read More
News
Thermo Fisher, Charles River join robotics outfit Multiply Labs’ quest to automate cell therapy production

Thermo Fisher, Charles River join robotics outfit Multiply Labs’ quest to automate cell therapy production

5 May 2022
...
Read More
Load More
Newsletter

Subscribe & get Company news.